| Literature DB >> 33243541 |
Sadegh Niazi1, Robert Groth1, Kirsten Spann2, Graham R Johnson3.
Abstract
Whether virulent human pathogenic coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2) are effectively transmitted by aerosols remains contentious. Transmission modes of the novel coronavirus have become a hot topic of research with the importance of airborne transmission controversial due to the many factors that can influence virus transmission. Airborne transmission is an accepted potential route for the spread of some viral infections (measles, chickenpox); however, aerosol features and infectious inoculum vary from one respiratory virus to another. Infectious virus-laden aerosols can be produced by natural human respiratory activities, and their features are vital determinants for virus carriage and transmission. Physicochemical characteristics of infectious respiratory aerosols can influence the efficiency of virus transmission by droplets. This critical review identifies studies reporting instances of infected patients producing airborne human pathogenic coronaviruses, and evidence for the role of physical/chemical characteristics of human-generated droplets in altering embedded viruses' viability. We also review studies evaluating these viruses in the air, field studies and available evidence about seasonality patterns. Ultimately the literature suggests that a proportion of virulent human coronaviruses can plausibly be transmitted via the air, even though this might vary in different conditions. Evidence exists for respirable-sized airborne droplet nuclei containing viral RNA, although this does not necessarily imply that the virus is transmittable, capable of replicating in a recipient host, or that inoculum is sufficient to initiate infection. However, evidence suggests that coronaviruses can survive in simulated droplet nuclei for a significant time (>24 h). Nevertheless, laboratory nebulized virus-laden aerosols might not accurately model the complexity of human carrier aerosols in studying airborne viral transport. In summary, there is disagreement on whether wild coronaviruses can be transmitted via an airborne path and display seasonal patterns. Further studies are therefore required to provide supporting evidence for the role of airborne transmission and assumed mechanisms underlying seasonality.Entities:
Keywords: Airborne transmission; Coronaviruses; SARS; Seasonality
Mesh:
Substances:
Year: 2020 PMID: 33243541 PMCID: PMC7645283 DOI: 10.1016/j.envpol.2020.115767
Source DB: PubMed Journal: Environ Pollut ISSN: 0269-7491 Impact factor: 8.071
Fig. 1The origin and generation mechanism of respiratory droplets.
Investigations of the diameter of particles generated from human respiratory activities.
| Particle size range (μm) of natural respiratory activities and the methods of measuring | |||||||
|---|---|---|---|---|---|---|---|
| Type of infection | Breathing | talking | coughing | sneezing | Methods of measuring size | Study | Year |
| Healthy subjects | <0.6 | <0.6 | <0.6 | – | Optical Particle Counter (OPC) | Papineni et al. ( | 1997 |
| – | ≤3.3 | – | Andersen Cascade Impactor (Pacitto et al.) | Fennelly et al. ( | 2004 | ||
| Healthy subjects | 015–0.19 | – | – | – | OPC (Optical diffraction) | Edwards et al. ( | 2004 |
| Healthy subjects | – | 0.62–15.9 | – | Aerodynamic Particle Sizer (George et al.) | Yang et al. ( | 2007 | |
| Unknown viral spp. | 0.3–0.5 | – | – | – | OPC (Optical diffraction) | Fabian et al. ( | 2008 |
| Healthy subject | – | <1 | – | APS (TOF) | Fang et al. ( | 2008 | |
| Healthy subjects and infected subjects by unknow viral spp. | H:0.09-<0.16 | – | – | – | Electrical Low-Pressure Impactor (ELPI) | Hersen et al. ( | 2008 |
| Healthy subjects | 0.1–1 | 0.1–1 | 0.1–1 | – | APS (TOF) | Morawska et al. ( | 2008 |
| Heathy subjects | ≈0.3–3 | – | – | – | APS (TOF) | Johnson et al. ( | 2009 |
| Healthy subjects | – | 4–8 | 4–8 | – | Interferometric Mie Imaging (IMI) | Chao et al. ( | 2009 |
| Healthy subjects | – | 50–75 | 50–75 | – | Droplet deposition (Analytical microscopy) | Xie et al. ( | 2009 |
| Healthy subjects | 0.4–1.1 | – | 0.4–10 | 0.4–4 | APS (TOF) | Morawska et al. ( | 2009 |
| Bacterial, unknown infection | – | – | ≤3.3 | – | ACI (Impaction) | Wainwright et al. ( | 2009 |
| Healthy subjects | 0.3–0.4 | – | – | – | OPC (Optical diffraction) | Almstrand et al. ( | 2010 |
| Healthy subjects | 0.1–7 | – | – | – | Laser Spectrometer (TOF) | Haslbeck et al. ( | 2010 |
| Healthy subjects | OPC: 0.4–4 | – | – | – | OPC (Optical diffraction) SMPS (Electrical mobility) | Holmgren et al. ( | 2010 |
| Heathy subjects | – | 0.1–1000 | 0.01–1000 | – | APS (TOF) | Johnson et al. ( | 2011 |
| 3 healthy and 16 human rhinovirus (HRV)-infected subjects | 0.3–0.5 | – | – | – | OPC with nominal diameter-size bins ranging between 0.3 μm and 10 mm | Patricia Fabian et al. ( | 2011 |
| Influenza, before and after recovery | – | – | H: 0.57–0.89 | – | Laser Spectrometer (TOF) | Lindsley et al. ( | 2012 |
| Influenza A and B, parainfluenza 1, 2 and 3, respiratory syncytial virus (RSV), human metapneumovirus and human rhinoviruses (hRV) | 58% of participants produced particles >5 μm and 80% produced particles (≤5 μm) | 57% of participants produced particles >5 μm and 82% produced particles (≤5 μm) | – | ACI (Impaction) | Jan Gralton et al. ( | 2013 | |
| Healthy subjects | – | – | – | First mode: 40–200, Second mode: 200-1000 | Laser Spectrometer (TOF) | Z. Y. Han et al. ( | 2013 |
| Healthy subjects | – | ≈0.5–10 | – | – | APS (TOF) | Sima Asadi et al. ( | 2019 |
Key: H: Healthy; I: Infected; DN: Droplet nuclei.
Organic and inorganic analysis of human pulmonary secretions (Potter et al., 1963).
| Infection type | Number of examined patients | mg protein/g secretion | mg lipid/g secretion | % Solids (g solids/l00g secreted fluid) | μEquivalent/gm of whole pulmonary secretions | ||||
|---|---|---|---|---|---|---|---|---|---|
| Na | Cl | Ca | P | K | |||||
| Cystic fibrosis | 24 | 55.7 ± 20.3 | 31.4 ± 9.7 | 10.68 ± 2.23 | 101 ± 27 | 75 ± 12 | 7.3 ± 1.9 | 127 ± 44 | 28 ± 8.2 |
| Bronchiectasis | 8 | 20.4 ± 4.5 | 11.7 ± 4.3 | 5.2 ± 1.21 | 116 ± 15 | 97 ± 14 | 9.3 ± 2.6 | 37 ± 9 | 18.7 ± 3.2 |
| Laryngectomized | 29 | 10.0 ± 3.0 | 8.4 ± 2.7 | 5.21 ± 1.69 | 165 ± 42 | 162 ± 60 | 6.2 ± 2.0 | 27 ± 16 | 13.2 ± 5.4 |
Note: The number of patients for measuring protein and lipid contents were 8 in each group.
Distribution of proteins of human mucosal fluids (Ali et al., 2011; Schenkels et al., 1995).
| Fluid type | Saliva | Bronchial Mucus | Nasal Mucus | Airway secretions |
|---|---|---|---|---|
| Mucins (% of total protein) | >15% | >15% | >15% | >15% |
| Acidic proline-rich proteins (% of total protein) | >15% | ND | ND | ND |
| a-Amylase (% of total protein) | >15% | <1% | <1% | <1% |
| Basic proline-rich proteins (% of total protein) | 5–15% | <1% | <1% | 1–5% |
| Basic proline rich glycoprotein (% of total protein) | 5–15% | ND | ND | ND |
| Secretory Immunoglobulin A (% of total protein) | 5–15% | ND | >15% | >15% |
| Cystatins (% of total protein) | 1–5% | ND | <1% | ND |
| Statherin (% of total protein) | 1–5% | <1% | <1% | <1% |
| Immunoglobulin G (% of total protein) | <1% | <1% | <1% | <1% |
| Extra-parotid glycoprotein (% of total protein) | <1% | ND | <1% | ND |
| Histatins (% of total protein) | <1% | ND | ND | ND |
| Lysozyme (% of total protein) | <1% | >15% | >15% | >15% |
| Kallikrein (% of total protein) | <1% | ND | <1% | ND |
| Lactoferrin (% of total protein) | <1% | >15% | >15% | >15% |
| Lactoperoxidase (% of total protein) | <1% | ND | <1% | ND |
| Haptocorrin (% of total protein) | <1% | ND | <1% | ND |
| B-Microseminoprotein (% of total protein) | <1% | 5–15% | <1% | <1% |
| Immunoglobulin M (% of total protein) | <1% | <1% | 5–15% | <1% |
| Albumin (% of total protein) | <1% | <1% | <1% | ND |
| Zn-a2 glycoprotein (% of total protein) | <1% | ND | ND | ND |
Studies of air sampling for coronaviruses (methods and conditions).
| Sampling site and location | Infection type | Sampling method | Sampling flow rate (sampling volume) | # of collected samples | # of positive samples | Study | Year |
|---|---|---|---|---|---|---|---|
| Patients’ room and rooms as control areas without housing SARS patients | SARS-CoV | PTFE membrane filter with a pore size of 0.3 μm | 2 L/min (1260–1560 L) | 40 | 2 (5%) | Booth et al. ( | 2005 |
| Camels’ barn | MERS-CoV | MD-8 airscan sampling device (Sartorius) and sterile gelatine filters | 50 L/min (1000 L) | 3 | 1 | Azhar et al. ( | 2014 |
| Patients’ rooms | MERS-CoV | MD-8 airscan sampler | 50 L/min (1000 L) | 7 | 4 | Kim et al. ( | 2016 |
| Patients’ rooms | SARS-CoV-2 | 37-mm filter cassettes and 0.3-μm polytetrafluoroethylene Filters/MD-8 airscan sampler | 6 m3/h (400 L)/6 m3/h (1500 L) | unknown | 0 | Ong et al. ( | 2020 |
| Patient areas, medical staff areas and public areas | SARS-CoV-2 | Filters (25 mm in diameter) loaded into styrene filter cassettes (SKC), miniature cascade impactor (Sioutas Impactor, SKC) and filters (80 mm in diameter) packed into a holder | 5 L/min (300 L) | 11,13 and 11 samples from patient areas, medical staff areas and public areas, respectively | 7,8 and 8 positive samples for patient areas, medical staff areas and public areas, respectively | Liu, Y. et al. ( | 2020 |
| Negative pressure isolation rooms | SARS-CoV-2 | MD8 airscan and personal air samplers | 50 L/min (750 L). | unknown | 63.2% | Santarpia JL et al. ( | 2020 |
| Hospital wards | SARS-CoV-2 | Impinger attached to a personal sample pump | 1 L/min (60 L) | 10 | 0 | Faridi et al. ( | 2020 |
| Hospital rooms | SARS-CoV-2 | NIOSH BC 251 bioaerosol samplers | 3.5 L/min (840 L) | 3 | 2 | Po Ying Chia, MBBS et al. ( | 2020 |
| Hospital rooms | SARS-CoV-2 | SAS Super ISO 180 model 86,834 (VWR International PBI Srl, Milan, Italy) | 180 L/min (1000 L) | 8 | 0 | VCC Cheng et al. ( | 2020 |
Field sampling for human coronaviruses.
| Sampling site and location | Infection type | Sampling method | # of collected samples | # of positive samples | Notes | Study | Year |
|---|---|---|---|---|---|---|---|
| SARS patients’ rooms and some rooms as control areas without housing SARS patients | Human coronavirus | Moisturised swabs; PCR for viral RNA and viral culture | 85 | 3 (3.5%) | A bedside table, remote control and a refrigerator handle at a nurses’ medication station were positive. All swabs were culture negative. | Booth et al. ( | 2005 |
| patient parts (patient rooms, nursing stations, emergency department) | SARS-CoV | Moisturised swabs; PCR for viral RNA and viral culture | 63 | 24 (38.1%) | 38.1% of 63 sites and 6.4% of 31 public areas were positive for SARS-CoV RNA. All swabs were culture negative. | Dowell et al. ( | 2004 |
| Jeddah airport, Saudi, Arabia | Human coronavirus (OC43/HKU1) | Moisturised swabs; PCR for viral RNA and viral culture | 40 | 3 (7.5%) | RNA was identified from surfaces. | Memish et al. ( | 2014 |
| Negative pressure isolation rooms | SARS-CoV-2 | Moisturised swabs; PCR for viral RNA and viral culture | 163 | 126 (77.3%) | 80.4% of all room surfaces, 76.5% of all personal items sampled and 81.0% Samples of the toilets in the room positive for SARS-CoV-2 RNA. All samples were culture negative | Santarpia JL et al. ( | 2020 |
| Patients’ room in hospital | SARS-CoV-2 | Pre-moistened macrofoam sterile swabs | 245 | 56.7% of the rooms had at least one environmental surfaces contamination. 18.5% of the toilet seats and button showed positive RT-qPCR results | Po Ying Chia, MBBS et al. ( | 2020 | |
| COVID-19 isolation ward | SARS-CoV-2 | Moisturised swabs; PCR for viral RNA | 37 | 9 (24.3%) | The most contaminated surfaces were hand sanitizer dispensers (100.0%), medical equipment (50.0%), medical equipment touch screens (50.0%), shelves for medical equipment (40.0%), bedrails (33.3%), and door handles (25.0%). | Katia Razzini et al. ( | 2020 |
| Quarantine room | SARS-CoV-2 | Moisturised swabs; PCR for viral RNA | 23 | 11 (47.8%) | 70% of samples from the bedroom followed by 50% of samples from the bathroom and that of 33% from the corridor were positive for SARS-CoV-2 | Xiaowen Hu et al. ( | 2020 |
Studies of viability of coronaviruses in simulated aerosols.
| Viability at different temperature and RH conditions | Type of spraying media | Aerosolization system | Collection system | study | Year | |
|---|---|---|---|---|---|---|
| 229E (HCV/229E) | At 20 ± 1 °C and 50% RH (half-life of 67.33 ± 8.24 h), at 20 ± 1 °C and 30% RH (half-life of 26.76 ± 6.21 h), at 20 ± 1 °C and 80 ± 5% RH (half-life of 3 h) | Tryptose phosphate broth with 2.5 mg of rhodamine B per mL | Collison nebulizer | Glass impinger | M. K. IJAZ et al. ( | 1985 |
| MERS-CoV | At 20 °C and 40% RH 7% reduction, at 20 °C and 70% RH 89% reduction | Unknown media | Collison nebulizer | Glass impinger | N van Doremalen1 et al. ( | 2013 |
| MERS-CoV | At 25 °C and 79% RH 63.5% survival after 60 min, at 38 °C and 24% RH 4.7% survival after 60 min | Unknown media | Collison nebulizer | Personal bioaerosol samplers with 40 mL of collecting liquid and 4 L/min flow rate | Oleg V. Pyankov et al. ( | 2017 |
| SARS-CoV | At 21–23 °C and 65% RH half time of 3 h | Unknown media | Collison nebulizer | Viruses were collected on a 47 mm gelatine filter and then dissolved in 10 mL of DMEM containing 10% FBS | Neeltje van Doremalen et al. ( | 2020 |
| SARS-CoV-2 | At 21–23 °C and 65% RH half time of 3 h | Unknown media | Collison nebulizer | Viruses were collected on a 47 mm gelatine filter and then dissolved in 10 mL of DMEM containing 10% FBS | Neeltje van Doremalen et al. ( | 2020 |
Relationship between incidence of coronaviruses and climatic variabilities.
| Study location | Study period | Study population | Infection type and Diagnostic test | Association with T | Association with RH | Other association | Statistical method | Author | Year |
|---|---|---|---|---|---|---|---|---|---|
| Guangzhou, China | January 2 to April 15, 2003 | laboratory-confirmed cases | SARS-CoV, clinical diagnosis | Tmax_7 (R = −0.438, P-value≤0.001) | RH_7 (R = −0.271, P-value≤0.001) | P_7 (R = −0.361, P-value≤0.001) | The lag = 7, simple correlation | Jianguo Tan et al. ( | 2004 |
| Beijing, China | March 5 to May 31, 2003 | laboratory-confirmed cases | SARS-CoV, clinical diagnosis | Tmax_7 (R = 0.528, P-value≤0.001) | RH_7 (R = −0.448, P-value≤0.001) | P_7 (R= −0.513, P-value≤0.001) | The lag = 7, simple correlation | Jianguo Tan et al. ( | 2004 |
| Taiyuan, China | March 7 to May 12, 2003 | laboratory-confirmed cases | SARS-CoV, clinical diagnosis | Tmax_7 (R = −0.310, p˂0.001) | RH_7 (R = −0.321, P-value≤0.001) | P_7 (R = −0.488, P-value≤0.001) | The lag = 7, simple correlation | Jianguo Tan et al. ( | 2004 |
| Hong Kong | February 15 to 31 May 2003 | laboratory-confirmed cases | SARS-CoV, clinical diagnosis | Tmax_7 = −0.453 | RH_7 (R = 0.067, NS) | P_7 (R = 0.364, P-value≤0.001) | The lag = 7, simple correlation | Jianguo Tan et al. ( | 2004 |
| Hong Kong | 11 March to 22 May 2003 | hospital staff | SARS-CoV, clinical signs, chest X-ray, diagnostic tests in some patients and/or autopsy | An increase of 1 °C in air temperature was related to an average reduction of 0.7 staff patients. | – | – | regression analysis (odd ratio). | Kun Lin et al. ( | 2005 |
| Beijing, China | April 3 to June 11, 2003 | laboratory-confirmed cases | clinical diagnosis | Temperature range (R = 0.337) | Relative humidity (R = −0.784) | Wind velocity (R = 0.617), Barometric pressure (R = 0.210), | Correlation | Jingsong Yuan et al. ( | 2006 |
| Hong Kong | April 21 to May 20, 2003 | laboratory-confirmed cases | SARS-CoV, clinical diagnosis | Tmax (R = −0.79), | RH (R = 0.24) | (R = 0.57) | Pearson’s correlation | P. Bi et al. ( | 2007 |
| Beijing, China | April 21 to May 20, 2003 | laboratory-confirmed cases | SARS-CoV, clinical diagnosis | Tmax (R = NS) | RH (R = −0.5) | (R = NS) | Pearson’s correlation | P. Bi et al. ( | 2007 |
| Worldwide | June 2012 to the Dec 2017. | Worldwide 2048 laboratory confirmed | MERS-CoV, clinical diagnosis | The highest global seasonal occurrence was found in the month of June, while the lowest was found in the month of January | – | – | M.S. Nassar et al. ( | 2018 | |
| Hubei Province, China | from January 23, 2020 to February 10, 2020. | SARS-CoV-2, clinical diagnosis | Tmean (R = −1.05 and P-value = 0.008) | – | Absolute Humidity (R = 0.761 and P-value = 0.048) | Loess regression and an exponential fit | Wei Luo et al. ( | 2020 | |
| 31 provincial-level regions in mainland China | between Jan 20 and Feb 29, 2020 | the number of new confirmed and probable cases were obtained from 101 the China National Health Commission (CNHC) | SARS-CoV-2, clinical diagnosis | – | – | No significant association between COVID-19 incidence and absolute humidity | regression and smoothing scatterplot | Peng Shi et al. ( | 2020 |
| Worldwide | COVID-19 Global Cases up to March 19, 2020 (13 and 7 countries with cold and warm climates. 4 countries considered as none | Worldwide laboratory confirmed | SARS-CoV-2, clinical diagnosis | Correlation between rate of spread and T (R = −0.72, P-value≤0.001) | Correlation between rate of spread and morning humidity (R = 0.2, P-value = 0.39) | Correlation between rate of spread and precipitation (R = −0.04, P-value = 0.87) | Pearson and Spearman correlation | Gil Caspi et al. ( | 2020 |